# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001642380-26-000008
Filing Date
2026-05-13
Accepted
2026-05-13 16:15:10
Documents
66
Period of Report
2026-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | imdx-20260331.htm iXBRL | 10-Q | 2482683
2 | EX-31.1 | imdx-ex31_1.htm | EX-31.1 | 14773
3 | EX-31.2 | imdx-ex31_2.htm | EX-31.2 | 14706
4 | EX-32.1 | imdx-ex32_1.htm | EX-32.1 | 11080
| Complete submission text file | 0001642380-26-000008.txt |  | 11601935

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | imdx-20260331.xsd | EX-101.SCH | 1637587
70 | EXTRACTED XBRL INSTANCE DOCUMENT | imdx-20260331_htm.xml | XML | 2268032

Mailing Address 2 INTERNATIONAL PLAZA DR., SUITE 510 NASHVILLE TN 37217
Business Address 2 INTERNATIONAL PLAZA DR., SUITE 510 NASHVILLE TN 37217 949-409-7600
Insight Molecular Diagnostics Inc. (Filer) CIK: 0001642380 (see all company filings)

EIN.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37648 | Film No.: 26973450
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)